[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355321-105":3,"doc-detail-355321-en":81,"detail-sidebar-cat-0-en-105":115},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-association-between-systemic-inflammation-markers-and-breast-cancer","The association between systemic inflammation markers and breast cancer","","The study evaluates how systemic inflammation markers relate to breast cancer prevalence and examines their potential biomarker value. Data from NHANES covering 2007–2016 were analyzed for 19,734 participants to test associations between six systemic inflammatory markers and breast cancer prevalence. Multivariable logistic regression, subgroup analyses, interaction testing, and ROC curve comparisons assessed predictive performance, with platelet-to-lymphocyte ratio showing significant positive correlation and leading diagnostic capability.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-association-between-systemic-inflammation-markers-and-breast-cancer/355321/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-association-between-systemic-inflammation-markers-and-breast-cancer/355321.png","ImageObject",300,407,{"name":42,"@type":43},"Mia  ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main objective of this study?","Question",{"text":63,"@type":64},"To evaluate the association between systemic inflammatory markers and breast cancer prevalence and explore their potential biomarker value.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which dataset and participant period were used?",{"text":68,"@type":64},"NHANES data were used, including surveys conducted between 2007 and 2016, after screening and exclusions.",{"name":70,"@type":61,"acceptedAnswer":71},"Which inflammation marker performed best in predicting breast cancer?",{"text":72,"@type":64},"The platelet-to-lymphocyte ratio (PLR) showed the strongest predictive performance in ROC analysis compared with other markers.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355321,1790176319,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":86,"file_id":87,"file_url":88,"file_type":89,"file_size":90,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":91,"language":92,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":93,"faqs":94,"seo_title":95,"seo_description":12,"update_tm":96,"read_time":97,"preview_page_count":33,"preview_urls":98},687207024478,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nThe association between systemic inflammation markers and breast cancer  \nSiQi Zhang1,5, Ran Li4,5, CuiTing Chen3,5, Miao Miao Liu3, JiaFeng Tang2􀀍 & Xiang Li3􀀍  \nBreast cancer is one of the most common malignant tumors in women worldwide. Inflammation plays an important role in the occurrence and development of breast cancer. This study aimed to evaluate the association between inflammatory markers and breast cancer prevalence and explore their potential biomarker value. Using data from the NHANES, approximately 20,000 participants were analyzed to assess the association between six systemic inflammatory markers and breast cancer prevalence. Statistical methods including multivariable logistic regression, subgroup analysis, and interaction testing were employed. ROC curves were used to evaluate and compare their diagnostic capabilities. This study included 19,734 participants. We observed a significant positive correlation between platelet-to-lymphocyte ratio (PLR) and breast cancer prevalence (OR = 1.35; 95% CI:1.09, 1.67), with PLR demonstrating good predictive performance for breast cancer. Additionally, monocyte-to-lymphocyte ratio (MLR), neutrophil-to-lymphocyte ratio (NLR), systemic immuneinflammation index (SII), systemic inflammation response index(SIRI) and aggregate index of systemic inflammation(AISI) were also found to be positively associated with breast cancer prevalence. Subgroup analysis and interaction tests revealed that the association between PLR and BC did not differ significantly among population groups. ROC curve analysis indicated that PLR (AUC = 0.59; 95%CI: 0.56, 0.63) outperformed other inflammatory markers in predicting BC. Systemic inflammatory markers, especially PLR, are significantly associated with BC prevalence and demonstrate potential as biomarkers for early detectionn. People with elevated inflammation markers should pay close attention to the latent prevalence of BC.  \nKeywords Platelet-to-lymphocyte ratio, Breast cancer, NAHNES, Cross-sectional study  \nAmong the most common malignant tumors worldwide, breast cancer ranks second in terms of cancer incidence in 2022. It represents a significant contributor to cancer-related mortality among women, accounting for approximately one-sixth of all female cancer deaths1. Countries with higher Human Development Index (HDI) tend to have higher breast cancer incidence rates, reflecting the prevalence of risk factors related to reproductive and lifestyle patterns. These risk factors include early menarche, late menopause, higher age at first childbirth, fewer children, less breastfeeding, hormone replacement therapy, oral contraceptive use, alcohol consumption, obesity, and lack of physical activity2. Given the scarcity of definitive modifiable risk factors, establishing a primary prevention strategy for breast cancer remains a significant challenge3,4.  \nDuring tumor initiation and development, inflammation plays a crucial role5,6. Tumor-infiltrating lymphocytes are important biomarkers for cancer stratification and can also serve as prognostic indicators7–9. Inflammation can be assessed using various biochemical or hematological markers10, and some inflammatory markers have been shown to be associated with cancer risk. These markers include the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), and systemic immuneinflammation index (SII)11. Some studies have observed associations between these indicators and cancer risk and mortality, but most research has focused on using these markers as prognostic indicators, and the results  \n1Department of Oncology, School of Medicine, Xiang’an Hospital of Xiamen University, Xiamen University, Xiamen 361102, Fujian, China. 2Chongqing Key Laboratory of Development and Utilization of Genuine Medicinal Materials in Three Gorges Reservoir Area, Chongqing Three Gorges Medical Co","cbCaiaAKbg4aGtij","https://ap.wps.com/l/cbCaiaAKbg4aGtij","pdf",2069592,10,"English","# Materials and methods\n## Data source\n## Statistical analysis\n## ROC curve evaluation","[{\"question\":\"What is the main objective of this study?\",\"answer\":\"To evaluate the association between systemic inflammatory markers and breast cancer prevalence and explore their potential biomarker value.\"},{\"question\":\"Which dataset and participant period were used?\",\"answer\":\"NHANES data were used, including surveys conducted between 2007 and 2016, after screening and exclusions.\"},{\"question\":\"Which inflammation marker performed best in predicting breast cancer?\",\"answer\":\"The platelet-to-lymphocyte ratio (PLR) showed the strongest predictive performance in ROC analysis compared with other markers.\"}]","The association between systemic inflammation markers and breast cancer | PDF",1790117749,25,[99,103,107,111],{"page_no":22,"url":100,"width":101,"height":102},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/59bbce125fcbab6e25d8b338a1393e03.webp",983,1291,{"page_no":26,"url":104,"width":105,"height":106},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f16f96e0f1cd2b4d4e254337db5500b.webp",982,1290,{"page_no":30,"url":108,"width":109,"height":110},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ba93311b8dee4bd731c3f0cd83959e1d.webp",981,1289,{"page_no":33,"url":112,"width":113,"height":114},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/829f54249dba2040f1eba8117f54d43a.webp",980,1287,{"code":4,"msg":82,"data":116},[117,121,125,129,134,139,144,147,152,155,158],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":118,"show_sort_weight":119,"slug":120},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":122,"show_sort_weight":123,"slug":124},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":126,"show_sort_weight":127,"slug":128},"Exam",70,"exam",{"id":130,"doc_module":4,"doc_module_name":25,"category_name":131,"show_sort_weight":132,"slug":133},5,"Comic",60,"comic",{"id":135,"doc_module":4,"doc_module_name":25,"category_name":136,"show_sort_weight":137,"slug":138},6,"Technology",50,"technology",{"id":140,"doc_module":4,"doc_module_name":25,"category_name":141,"show_sort_weight":142,"slug":143},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":145,"slug":146},30,"research-report",{"id":148,"doc_module":4,"doc_module_name":25,"category_name":149,"show_sort_weight":150,"slug":151},9,"Religion & Spirituality",20,"religion-spirituality",{"id":150,"doc_module":4,"doc_module_name":25,"category_name":153,"show_sort_weight":150,"slug":154},"World Cup","world-cup",{"id":91,"doc_module":4,"doc_module_name":25,"category_name":156,"show_sort_weight":91,"slug":157},"Lifestyle","lifestyle",{"id":159,"doc_module":4,"doc_module_name":25,"category_name":160,"show_sort_weight":130,"slug":161},19,"General","general"]